Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Smith & Nephew plc

Cyber Surgery develops innovative robotic assistants for seamless spinal procedures, focusing on surgical planning and vertebral fusion.

Cyber Surgery

EPICA International develops, sells, and services advanced medical imaging platforms and robotic systems. They provide solutions for both human and animal imaging.

EPICA International

Karl Storz is a leading global manufacturer and supplier of endoscopy equipment and medical devices.

Karl Storz

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. This is self-described.

Metric
Company Name	Smith & Nephew plc	Cyber Surgery	EPICA International	Karl Storz
Symbol	SN
MSH ID	COM:SMITH-NEPHEW	COM:CYBER-SURGERY	COM:EPICAINTERNATIONAL	COM:KARLSTORZ
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Medical - Devices	Medical Devices	Medical Devices	Medical Devices
Country	GB	ES	US	DE
Stage		Non Equity Assistance	Debt Financing
Employee Count	18.45K			3.79K
Website	smith-nephew.com	cyber-surgery.com	epicainternational.com	karlstorz.com
LinkedIn		cyber-surgery		karlstorz
Founders

Metric
Market Cap	120.67M
Enterprise Value
Monthly Web Traffic		463	88	109.52K
Web Traffic Growth			-0.94	0.21
Valuation
Raised Capital			13.50M

Metric
Revenue	5.55B
Revenue (LTM)
Revenue (NTM)
Gross Profit	3.82B
EBITDA	1.19B
Operating Income	425M
Net Income	263M
EPS	0.30
Diluted EPS	0.30
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.70
Operating Profit Margin	0.13
EBITDA Margin	0.21
Net Profit Margin	0.05
Return on Equity	0.06
Return on Assets	0.03
Return on Capital Employed	0.09

COM:SMITH-NEPHEW

Smith+Nephew

Last Close

986.80

25/11 09:24

Market Cap

94.69M

Beta: -

Volume Today

86.36K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	55.91
P/B Ratio	2.37
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.44
EV Multiple	10.05

Metric
Days Sales Outstanding
Days Payables Outstanding	260.24
Days Inventory Outstanding	552.23
Operating Cycle	630.80
Cash Conversion Cycle	407.53
Asset Turnover	0.56

Metric
Operating Cash Flow	608M
Free Cash Flow	181M
Cash Flow to Debt	0.20
Operating Cash Flow/Sales	0.13
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	302M
Accounts Receivable
Inventory	2.40B
Goodwill	2.99B
Debt to Capitalization	0.41
Debt to Assets	0.29
Current Ratio	2.25
Quick Ratio	1.11

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.07
SG&A to Revenue	0.55